Markets&Markets

akthealth Oct 25, 2024 11:39 2286

Markets&Markets

https://www.einpresswire.com/article/750271456/how-decentralized-clinical-trials-and-real-world-evidence-are-redefining-clinical-trials

Previous Article

DCTs Quarterly Series Japan 2024: Transforming Clinical Trials and Pharma in Tokyo

Next Article

DCT 2024

What's Your Reaction?

0

0

0

0

0

0

0

Thoughts from AKTHealth

AKT HEALTH ANALYTICS PARTNERS WITH SWAROOP TECH SERVICES. PVT LTD

AKT HEALTH ANALYTICS PARTNERS WITH SWAROOP TECH SERVICES....

Meghana Jan 22, 2021 4205

AKT Has partnered with Swaroop Tech Services Pvt. Ltd. to promote and distribute...

GVHS2021

K. BHADRAYYA - GVHS 2021 Speaker

K. BHADRAYYA - GVHS 2021 Speaker

Meghana Jul 5, 2021 3459

Kalva Bhadrayya is the founder and Director, Swaroop Tech Services Pvt.Ltd at Hyderabad.

GVHS2022

Prof. Prasun Kumar Roy - GVHS2022 Speaker

Prof. Prasun Kumar Roy - GVHS2022 Speaker

Meghana Nov 29, 2022 3919

GVHS2022 along with its partners and sponsors brings its summit into 3rd year in...

GVHS2020

GVHS2020 Speaker - Mansi Dholakia

GVHS2020 Speaker - Mansi Dholakia

Meghana Aug 24, 2020 5493

GVHS2020 brings together individuals from pharma, healthcare, Clinical and IT sector...

Technology

Blockchain technology for improving clinical research quality

Blockchain technology for improving clinical research quality

Meghana Apr 16, 2020 4106

A blockchain serves as a distributed database which maintains a continuously growing...

Clinical

Remdesivir for Coronavirus

Remdesivir for Coronavirus

Meghana May 6, 2020 4464

Currently remdesivir has not been approved by health authorities around the world,...

GVHS2022

GVHS2022 Speaker: Dr. Eiji Sasahara

GVHS2022 Speaker: Dr. Eiji Sasahara

Hema Dubey Nov 11, 2022 2257

Dr. Eiji Sasahara, Ph.D., MBA, Partner of Healthcare Cloud Initiative, NPO will...

GVHS2022

Mr. Takanori Ogawa - GVHS2022 Speaker

Mr. Takanori Ogawa - GVHS2022 Speaker

Meghana Nov 11, 2022 2429

GVHS2022 along with its partners and sponsors brings its summit into 3rd year in...

Events

DCTs Quarterly Series Japan 2024: Transforming Clinical Trials and Pharma in Tokyo

DCTs Quarterly Series Japan 2024: Transforming Clinical...

Hema Dubey Sep 30, 2024 2515

AKT Health is excited to announce the DCTs Quarterly Series Japan 2024, launching...

GVHS2021

Dr. Keith Nieforth - GVHS 2021 Speaker

Dr. Keith Nieforth - GVHS 2021 Speaker

Meghana Jul 14, 2021 3854

AKT Health Analytics brings to you Global Virtual Healthcare Summit #GVHS2021 -...

What is the impact of your current operational response to COVID-19?

Minimum impact, most employees can work from home

Moderate impact, some employees need to work on-site

Significant impact, most employees need to work on-site

Total impact, complete shut down

Please select an option!

You already voted this poll before.

What is the impact of your current operational response to COVID-19?

Total Vote: 2

Minimum impact, most employees can work from home

0 %

Moderate impact, some employees need to work on-site

50 %

Significant impact, most employees need to work on-site

50 %

Total impact, complete shut down

0 %